Skip to content

Insider · CIK 0001419488

Chamoun George

ceoofficerdirector

Files at ACVA (ACV Auctions Inc.). First filing Dec 12, 2024, latest Dec 12, 2024.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $7.6M sold

Signals

This insider’s open-market buys and sells, scored.

ScoreSideCompanyValueSharesHoldings changePrice contextFiled
55Moderatesell 410b5-1ACVA
ACV Auctions Inc.
$7.6M350,000-32%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Dec 10, 2024ACVA
ACV Auctions Inc.
CConversion
Class A Common Stock10b5-1
+187,717--1,082,804Dec 12, 2024
Dec 10, 2024ACVA
ACV Auctions Inc.
SOpen-market sale
Class A Common Stock10b5-1
-210,400$21.64$4.6M872,404Dec 12, 2024
Dec 11, 2024ACVA
ACV Auctions Inc.
CConversion
Class A Common Stock10b5-1
+139,600--1,012,004Dec 12, 2024
Dec 11, 2024ACVA
ACV Auctions Inc.
SOpen-market sale
Class A Common Stock10b5-1
-139,600$21.66$3.0M872,404Dec 12, 2024
Dec 12, 2024ACVA
ACV Auctions Inc.
CConversion
Class A Common Stock10b5-1
+500,000--1,372,404Dec 12, 2024
Dec 12, 2024ACVA
ACV Auctions Inc.
GGift
Class A Common Stock10b5-1
-250,000$0.00$01,122,404Dec 12, 2024
Dec 12, 2024ACVA
ACV Auctions Inc.
GGift
Class A Common Stock10b5-1
-250,000$0.00$0872,404Dec 12, 2024
Dec 10, 2024ACVA
ACV Auctions Inc.
CConversion
Class B Common Stockderivative10b5-1
-187,717$0.00$01,525,448Dec 12, 2024
Dec 11, 2024ACVA
ACV Auctions Inc.
CConversion
Class B Common Stockderivative10b5-1
-139,600$0.00$01,385,848Dec 12, 2024
Dec 12, 2024ACVA
ACV Auctions Inc.
CConversion
Class B Common Stockderivative10b5-1
-500,000$0.00$0885,848Dec 12, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.